Insider plans 61,745-share sale in company (NASDAQ: DRTS)

Rhea-AI Filing Summary

Form 144 for DRTS reports a planned sale of ordinary shares. The notice covers 61,745 ordinary shares to be sold through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $364,295.50 and 70,380,570 shares outstanding. The shares to be sold were acquired on 02/21/2017 under an employee stock option plan from the issuer, with cash paid upon exercise.

Over the prior three months, the filer, Gat Amnon, sold additional ordinary shares of the same issuer: 16,000 shares on 11/03/2025 for $62,404.91, 33,351 shares on 12/01/2025 for $148,918.59, and 33,351 shares on 01/02/2026 for $166,120.25. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co Inc. Broad 85 St. New York NY 10004	61745	364295.50	70380570	01/08/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	02/21/2017	Employee Stock Options plan	Issuer			61745	02/21/2017	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gat Amnon KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary	11/03/2025	16000	62404.91
Gat Amnon KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary	12/01/2025	33351	148918.59
Gat Amnon KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary	01/02/2026	33351	166120.25

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DRTS Form 144 filing disclose?

The Form 144 discloses that a holder of DRTS ordinary shares has filed notice to sell 61,745 ordinary shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $364,295.50.

How many DRTS shares has the filer sold in the past three months?

Over the past three months, Gat Amnon sold DRTS ordinary shares in three transactions: 16,000 shares on 11/03/2025, 33,351 shares on 12/01/2025, and 33,351 shares on 01/02/2026.

What were the gross proceeds from the recent DRTS share sales?

The gross proceeds from the recent sales were $62,404.91 for 16,000 shares, $148,918.59 for 33,351 shares, and $166,120.25 for another 33,351 shares.

How were the DRTS shares being registered on Form 144 originally acquired?

The 61,745 DRTS ordinary shares covered by this Form 144 were acquired on 02/21/2017 under an employee stock options plan from the issuer, with cash upon exercise as the nature of payment.

What is the total number of DRTS shares outstanding referenced in the Form 144?

The Form 144 notes that there are 70,380,570 ordinary shares of the issuer outstanding.

Which broker and exchange are involved in the planned DRTS share sale?

The planned sale of 61,745 ordinary shares is through Oppenheimer & Co. Inc., with the securities to be sold on the Nasdaq exchange.